Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion type Assertion NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_head.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion description "[Here, we show by immunohistochemistry, in patients receiving androgen ablation therapy, that sPLA(2)-IIA remains elevated in remaining cancer cells relative to benign glands after treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_provenance.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion evidence source_evidence_literature NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_provenance.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion SIO_000772 15466184 NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_provenance.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion wasDerivedFrom befree-20150227 NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_provenance.
- NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_assertion wasGeneratedBy ECO_0000203 NP627841.RAJqDWum3d5xfQFgyscbAuKVVl2XnmxdRAN4KruE-2rCg130_provenance.